Ortho Dermatologics

Ortho Dermatologics company information, Employees & Contact Information

Ortho Dermatologics is one of the largest prescription dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. The Ortho Dermatologics portfolio includes several leading acne, anti-fungal and corticosteroid-responsive dermatoses products. See our community guidelines at https://www.bauschhealth.com/social-media/.

Company Details

Employees
106
Address
400 Somerset Corporate Center, Bridgewater,nj 08807,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Dermatology.
HQ
Bridgewater, NJ
Looking for a particular Ortho Dermatologics employee's phone or email?

Ortho Dermatologics Questions

News

Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program - PR Newswire

Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program PR Newswire

Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide - Walgreens Boots Alliance

Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide Walgreens Boots Alliance

Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients - Yahoo Finance

Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients Yahoo Finance

Big Pharma just started copying the buzzy startups that ship Viagra and hair-loss pills to your door, and it could be the start of a 'mega-trend' - businessinsider.com

Big Pharma just started copying the buzzy startups that ship Viagra and hair-loss pills to your door, and it could be the start of a 'mega-trend' businessinsider.com

FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris - CNN

FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris CNN

FDA Accepts NDA for Plaque Psoriasis Treatment Jemdel - Medical Professionals Reference

FDA Accepts NDA for Plaque Psoriasis Treatment Jemdel Medical Professionals Reference

Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference - PR Newswire

Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference PR Newswire

Valeant to Buy Janssen’s Ortho Dermatologics Business for $345M - Genetic Engineering and Biotechnology News

Valeant to Buy Janssen’s Ortho Dermatologics Business for $345M Genetic Engineering and Biotechnology News

IDP-126 Approved by FDA for Treatment of Acne - Dermatology Times

IDP-126 Approved by FDA for Treatment of Acne Dermatology Times

Big Pharma just pulled the plug on its first attempt to copy the buzzy startups that ship Viagra and hair-loss pills to your door - businessinsider.com

Big Pharma just pulled the plug on its first attempt to copy the buzzy startups that ship Viagra and hair-loss pills to your door businessinsider.com

FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old - CNN

FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old CNN

FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older - Yahoo Finance

FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older Yahoo Finance

Arazlo Lotion Approved for Acne Vulgaris - Medical Professionals Reference

Arazlo Lotion Approved for Acne Vulgaris Medical Professionals Reference

Ortho Dermatologics Receives FDA Approval For ALTRENO™ (tretinoin 0.05%) Lotion For Acne - PR Newswire

Ortho Dermatologics Receives FDA Approval For ALTRENO™ (tretinoin 0.05%) Lotion For Acne PR Newswire

Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference - PR Newswire

Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference PR Newswire

Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States - PR Newswire

Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States PR Newswire

Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection - PR Newswire

Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection PR Newswire

Ortho Dermatologics Launches Arazlo (Tazarotene) Lotion In The United States - Reuters

Ortho Dermatologics Launches Arazlo (Tazarotene) Lotion In The United States Reuters

Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults - PR Newswire

Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults PR Newswire

CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. - Yahoo Finance

CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Yahoo Finance

FDA Approves the Use of Luzu Cream in Younger Patients - Medical Professionals Reference

FDA Approves the Use of Luzu Cream in Younger Patients Medical Professionals Reference

FDA Accepts NDA for Topical Combination Treatment for Plaque Psoriasis - Medical Professionals Reference

FDA Accepts NDA for Topical Combination Treatment for Plaque Psoriasis Medical Professionals Reference

Arazlo Lotion Now Available for Acne Vulgaris - Medical Professionals Reference

Arazlo Lotion Now Available for Acne Vulgaris Medical Professionals Reference

APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10% - PR Newswire

APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10% PR Newswire

Bausch Health Announces U.S. Launch Of BRYHALI™ (halobetasol propionate) Lotion, 0.01%, For Plaque Psoriasis In Adults - PR Newswire

Bausch Health Announces U.S. Launch Of BRYHALI™ (halobetasol propionate) Lotion, 0.01%, For Plaque Psoriasis In Adults PR Newswire

Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark - PR Newswire Canada

Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark PR Newswire Canada

Ortho Dermatologics’ Arazlo Anti-acne Lotion Available in the U.S. - Cosmetics & Toiletries

Ortho Dermatologics’ Arazlo Anti-acne Lotion Available in the U.S. Cosmetics & Toiletries

Top Ortho Dermatologics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant